Open access
Aug 2026
Targeting PKM2 Enhances the Anti-Tumor Function of CD8+ T Cells Through Metabolic Reprogramming
It is demonstrated that in vitro metabolic pretreatment via PKM2 activation represents an effective translational strategy for optimizing the anti-tumor efficacy of ACT cell products.
Jun-Xiu Zhang, Shu-Yi Wu, Qin Yin et al.
· International Journal of Mol... · 0 citations